Charting a new course in brain tumor treatment

We provide patients with precise diagnoses and personalized treatments, enabled by:

• UCSF500 Cancer Gene Panel, a molecular diagnostic tool to identify targeted therapies
• DNA methylation profiling for accurate tumor classification
• Spatial sampling to generate 3D models of brain tumors and identify new pathways for targeted therapies
• Neuroimaging techniques to detect brain tumor response to treatment

UCSF has been the #1 NIH-funded institution in neurosurgery for more than a decade. We integrate research across patient care through:

• More than 30 labs working to develop next-generation brain tumor treatments
• Clinical trials, including using CAR T-cell immunotherapy for glioblastoma, focused ultrasound to deliver treatments across the blood-brain barrier, and gene expression to determine if patients need radiotherapy
• Advanced AI tools for fast, accurate diagnoses and more complete resection